As we reach the halfway point of 2026, I’ve been reflecting on what has made the first six months so rewarding at Ciencia Research.
One of the things I value most about being CEO is that it has never meant stepping away from the science. Quite the opposite. Alongside leading the business, I remain closely involved in client work and scientific projects, from evidence generation and real-world studies to market access, stakeholder engagement and support for interactions with regulators, HTA agencies and payers.
That closeness to the work matters.
Behind every dataset and every research question are patients, healthcare professionals and important decisions that need to be made with confidence. Whether we are mapping patient journeys, identifying barriers to care or generating evidence to support innovation, our goal remains clear: to help ensure new treatments reach the patients who need them.
I am also continually impressed by the Ciencia Research team. Our epidemiologists and scientific experts bring deep knowledge, curiosity, pragmatism and a real commitment to quality. They challenge each other, challenge me and keep finding ways forward when the answer is not immediately obvious.
The first half of 2026 has also brought some important scientific milestones. We recently presented results from a large study in warm autoimmune hemolytic anaemia (wAIHA) at the EHA Congress.
Two publications will soon follow, including one on pregnancy outcomes among women with autoimmune diseases following its presentation at EULAR, and another on healthcare resource utilisation, costs and survival in diffuse large B-cell lymphoma.
I am grateful to our clients and partners for trusting us with important scientific and strategic challenges. I am proud of the work our team is doing. And I am delighted that Ciencia Research was recently featured as one of Sweden’s Innovative Companies by Svenska Dagbladet.
Good science does more than answer research questions. It helps shape decisions, supports innovation and improves the journey for patients.
I look forward to sharing more in the months ahead.
Pernilla Meijer
Chief Executive Officer, Ciencia Research AB
Contact me to learn more:
pernilla.meijer@cienciaresearch.com
#evidencegenerationservices
#evidencestrategy
#realworldevidenceservices
#RWEconsultants
#Nordichealthdataanalysis
